Connecticut 2022 Regular Session Status: Enacted Bipartisan · 25 D · 14 R cosponsors

SB 358 — AN ACT CONCERNING REQUIRED HEALTH INSURANCE COVERAGE FOR BREAST AND OVARIAN CANCER SUSCEPTIBILITY SCREENING.

Last action — SIGNED BY GOVERNOR

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. ✓
    Passed Senate
  4. ✓
    Passed House
  5. ✓
    To Executive
  6. 6
    Enacted

This bill has been enacted into law. Introduced March 07, 2022. Enacted.

Prognosis

Likely to advance 78% · moderate confidence

Where this bill stands today.

Odds of enactment

High

How often bills like it became law.

  • Enacted

    Current position in the legislative process.

  • 62 sponsors

    62 primary, 0 co-sponsors signed on.

  • Bipartisan support

    Sponsored across 2 parties (25 D · 14 R) — cross-party backing.

Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.

Bill Text

What changed in the latest version

401 added · 424 removed

401 line(s) added, 424 removed.

→
Previous
Latest
General Assembly Substitute Bill No.
Substitute Senate Bill No.
358 February Session, 2022 AN ACT CONCERNING REQUIRED HEALTH INSURANCE COVERAGE FOR BREAST AND OVARIAN CANCER SUSCEPTIBILITY SCREENING.
358 Public Act No.
22-90 AN ACT CONCERNING REQUIRED HEALTH INSURANCE COVERAGE FOR BREAST AND OVARIAN CANCER SUSCEPTIBILITY SCREENING.
(b) (1) Each individual health insurance policy providing coverage of thetypespecifiedinsubdivisions(1),(2),(4),(10),(11)and(12)ofsection LCO \\PRDFS1\SCOUSERS\FORZANOF\WS\2022SB-00358-R1 of 14 SB.docx Substitute Bill No.
(b) (1) Each individual health insurance policy providing coverage of thetypespecifiedinsubdivisions(1),(2),(4),(10),(11)and(12)ofsection Substitute Senate Bill No.
(A) A baseline mammogram [, which may be provided by breast tomosynthesisat theoptionofthewomancoveredunder thepolicy,]for [any woman] an insured who is:
(A) A baseline mammogram, which may be provided by breast tomosynthesis at the option of the [woman] insured covered under the policy, for [any woman] an insured who is:
or (IV) Other indications as determined by the insured's physician, advanced practice registered nurse, physician's assistant, certified nurse midwife or other medical provider;
or (IV) Other indications as determined by the insured's physician, advanced practice registered nurse, physician assistant, certified nurse midwife or other medical provider;
and (B) [a mammogram] Mammograms, which may be provided [by breast tomosynthesis at the option of the woman covered under the policy,] every year for [any woman] an insured who is:
and (B) [a mammogram] Mammograms, which may be provided by breast tomosynthesis at the option of the [woman] insured covered under the policy, every year for [any woman] an insured who is:
(I) A family history, or prior personal history, of breast cancer;
Public Act No.
LCO {\\PRDFS1\SCOUSERS\FORZANOF\WS\2022SB-0032 of 14 R02-SB.docx } Substitute Bill No.
22-90 2 of 15 Substitute Senate Bill No.
358 (II) Positive genetic testing for the harmful variant of breast cancer gene one, breast cancer gene two or any other gene that materially increases the insured's risk for breast cancer;
358 (I) A family history, or prior personal history, of breast cancer;
(II) Positive genetic testing for the harmful variant of breast cancer gene one, breast cancer gene two or any other gene that materially increases the insured's risk for breast cancer;
or (IV) Other indications as determined by the insured's physician, advanced practice registered nurse, physician's assistant, certified nurse midwife or other medical provider.
or (IV) Other indications as determined by the insured's physician, advanced practice registered nurse, physician assistant, certified nurse midwife or other medical provider.
[,] (II) [positive] Positive genetic testing [, or] for the harmful variant of breast cancer gene one, breast cancer gene two or any other gene that materially increases the insured's risk for breast cancer;
[,] (II) [positive] Positive genetic testing [, or (III) other] for the harmful variant of breast cancer gene one, breast cancer gene two or any other gene that materially increases the insured's risk for breast cancer;
or [(III) other] (IV) Other indications as determined by [a woman's] the insured'sphysician, [physicianassistant or advancedpractice registered nurse;
or Public Act No.
or (iii) such screening is recommended by a woman's treating physician for a woman who (I) is forty years of age or older, (II) has a LCO {\\PRDFS1\SCOUSERS\FORZANOF\WS\2022SB-0033 of 14 R02-SB.docx } Substitute Bill No.
22-90 3 of 15 Substitute Senate Bill No.
358 family history or prior personal history of breast cancer, or (III) has a prior personal history of breast disease diagnosed through biopsy as benign;
358 (IV) Other indications as determined by [a woman's] the insured's physician, [physician assistant or advanced practice registered nurse;
and] advanced practice registered nurse, physician's assistant, certified nurse midwife or other medical provider;
or (iii)suchscreening isrecommendedby awoman'streating physicianfor a woman who (I) is forty years of age or older, (II) has a family history or prior personal history of breast cancer, or (III) has a prior personal history of breast disease diagnosed through biopsy as benign;
and] advanced practice registered nurse, physician assistant, certified nurse midwife or other medical provider;
(i) [in] In accordance with guidelines established by the American Cancer Society [.] for an insured who is thirty-five years of age or older;
[in] (i) In accordance with guidelines established by the American Cancer Society [.] for an insured who is thirty-five years of age or older;
or (IV) Other indications as determined by the insured's physician, advanced practice registered nurse, physician's assistant, certified nurse midwife or other medical provider;
or (IV) Other indications as determined by the insured's physician, advanced practice registered nurse, physician assistant, certified nurse midwife or other medical provider;
(D) Prophylactic mastectomies for an insured who is believed to be at increased risk for breast cancer due to positive genetic testing for the harmful variant of breast cancer gene one, breast cancer gene two or any other gene that materially increases the insured's risk for breast cancer;
(D) Prophylactic mastectomies for an insured who is believed to be at increased risk for breast cancer due to positive genetic testing for the Public Act No.
22-90 4 of 15 Substitute Senate Bill No.
358 harmful variant of breast cancer gene one, breast cancer gene two or any other gene that materially increases the insured's risk for breast cancer;
LCO {\\PRDFS1\SCOUSERS\FORZANOF\WS\2022SB-00358-4 of 14 R02-SB.docx } Substitute Bill No.
(i) A prophylactic mastectomy;
358 (i) A prophylactic mastectomy;
(c)Benefits under this sectionshallbesubject to any policy provisions that apply to other services covered by such policy, except that no such policy shall impose a coinsurance, copayment, deductible or other out- of-pocket expense for such benefits.
(c)Benefits under thissectionshallbesubject to any policy provisions that apply to other services covered by such policy, except that no such policy shall impose a coinsurance, copayment, deductible or other out- of-pocket expense for such benefits.
"If your mammogram demonstrates that you have dense breast tissue, which could hide small abnormalities, you might benefit from supplementary screening tests, which can include a breast ultrasound screening or a breast MRI examination, or both, depending on your individual risk factors.
"If your mammogram demonstrates that you have dense breast tissue, which could hide small abnormalities, you might benefit from supplementary screening tests, which can include a breast Public Act No.
22-90 5 of 15 Substitute Senate Bill No.
358 ultrasound screening or a breast MRI examination, or both, depending on your individual risk factors.
LCO {\\PRDFS1\SCOUSERS\FORZANOF\WS\2022SB-0035 of 14 R02-SB.docx } Substitute Bill No.
Sec.
358 Sec.
(A) A baseline mammogram [, which may be provided by breast tomosynthesisat theoptionofthewomancoveredunder thepolicy,]for [any woman] an insured who is:
(A) A baseline mammogram, which may be provided by breast tomosynthesis at the option of the [woman] insured covered under the policy, for [any woman] an insured who is:
[thirty-five] (i) Thirty-five to thirty-nine years of age, inclusive;
[thirty-five] Public Act No.
22-90 6 of 15 Substitute Senate Bill No.
358 (i) Thirty-five to thirty-nine years of age, inclusive;
(II) Positive genetic testing for the harmful variant of breast cancer gene one, breast cancer gene two or any other gene variant that LCO {\\PRDFS1\SCOUSERS\FORZANOF\WS\2022SB-0036 of 14 R02-SB.docx } Substitute Bill No.
(II) Positive genetic testing for the harmful variant of breast cancer gene one, breast cancer gene two or any other gene variant that materially increases the insured's risk for breast cancer;
358 materially increases the insured's risk for breast cancer;
or (IV) Other indications as determined by the insured's physician, advanced practice registered nurse, physician's assistant, certified nurse midwife or other medical provider;
or (IV) Other indications as determined by the insured's physician, advanced practice registered nurse, physician assistant, certified nurse midwife or other medical provider;
and (B) [a mammogram, which may be provided by breast tomosynthesis at the option of the woman covered under the policy,] Mammograms every year for [any woman] an insured who is:
and (B) [a] A mammogram, which may be provided by breast tomosynthesis at the option of the [woman] insured covered under the policy, every year for [any woman] an insured who is:
(III) Prior treatment for a childhood cancer if the course of treatment for the childhood cancer included radiation therapy directed at the chest;
(III) Prior treatment for a childhood cancer if the course of treatment for the childhood cancer included radiation therapy directed at the Public Act No.
Show all 88 changed rows (48 more)
Previous
Latest
or (IV) Other indications as determined by the insured's physician, advanced practice registered nurse, physician's assistant, certified nurse midwife or other medical provider.
22-90 7 of 15 Substitute Senate Bill No.
358 chest;
or (IV) Other indications as determined by the insured's physician, advanced practice registered nurse, physician assistant, certified nurse midwife or other medical provider.
LCO {\\PRDFS1\SCOUSERS\FORZANOF\WS\2022SB-003587 of 14 R02-SB.docx } Substitute Bill No.
(i) A mammogram demonstrates heterogeneous or dense breast tissue based on the Breast Imaging Reporting and Data System established by the American College of Radiology;
358 (i) A mammogram demonstrates heterogeneous or dense breast tissue based on the Breast Imaging Reporting and Data System established by the American College of Radiology;
[,] (II) [positive] Positive genetic testing [, or] for the harmful variant of breast cancer gene one, breast cancer gene two or any other gene that materially increases the insured's risk for breast cancer;
[,] (II) [positive] Positive genetic testing [, or (III) other] for the harmful variant of breast cancer gene one, breast cancer gene two or any other gene that materially increases the insured's risk for breast cancer;
or [(III) other] (IV) Other indications as determined by [a woman's] the insured'sphysician, [physicianassistant or advancedpractice registered nurse;
or (IV) Other indications as determined by [a woman's] the insured's physician, [physician assistant or advanced practice registered nurse;
or (iii) such screening is recommended by a woman's treating physician for a woman who (I) is forty years of age or older, (II) has a family history or prior personal history of breast cancer, or (III) has a prior personal history of breast disease diagnosed through biopsy as benign;
or (iii)suchscreening isrecommendedby awoman'streating physicianfor a woman who (I) is forty years of age or older, (II) has a family history or prior personal history of breast cancer, or (III) has a prior personal history of breast disease diagnosed through biopsy as benign;
and] advanced practice registered nurse, physician's assistant, certified nurse midwife or other medical provider;
and] advanced practice registered nurse, physician assistant, certified nurse midwife or other medical provider;
(B)[Magnetic] Diagnosticandscreening magnetic resonance imaging of an entire breast or breasts:
Public Act No.
(i) [in] In accordance with guidelines established by the American Cancer Society [.] for an insured who is thirty-five years of age or older;
22-90 8 of 15 Substitute Senate Bill No.
358 (B)[Magnetic] Diagnosticandscreening magnetic resonance imaging of an entire breast or breasts:
[in] (i) In accordance with guidelines established by the American Cancer Society [.] for an insured who is thirty-five years of age or older;
LCO {\\PRDFS1\SCOUSERS\FORZANOF\WS\2022SB-0038 of 14 R02-SB.docx } Substitute Bill No.
(II) Positive genetic testing for the harmful variant of breast cancer gene one, breast cancer gene two or any other gene that materially increases the insured's risk for breast cancer;
358 (II) Positive genetic testing for the harmful variant of breast cancer gene one, breast cancer gene two or any other gene that materially increases the insured's risk for breast cancer;
or (IV) Other indications as determined by the insured's physician, advanced practice registered nurse, physician's assistant, certified nurse midwife or other medical provider;
or (IV) Other indications as determined by the insured's physician, advanced practice registered nurse, physician assistant, certified nurse midwife or other medical provider;
or (ii) A mastectomy as part of the insured's course of treatment for breast cancer.
or (ii) A mastectomy as part of the insured's course of treatment for Public Act No.
22-90 9 of 15 Substitute Senate Bill No.
358 breast cancer.
The provisions of this subsection shall apply to a high deductible health plan, as that term is used in subsection (f) of section 38a-520, to the maximum extent permitted by federal law, except if such plan is used to establish a medical savings account or an Archer MSA pursuant to Section 220 of the Internal Revenue Code of 1986 or any subsequent corresponding internal revenue code of the United States, as amended from time to time, or a LCO {\\PRDFS1\SCOUSERS\FORZANOF\WS\2022SB-0039 of 14 R02-SB.docx } Substitute Bill No.
The provisions of this subsection shall apply to a high deductible health plan, as that term is used in subsection (f) of section 38a-520, to the maximum extent permitted by federal law, except if such plan is used to establish a medical savings account or an Archer MSA pursuant to Section 220 of the Internal Revenue Code of 1986 or any subsequent corresponding internal revenue code of the United States, as amended from time to time, or a health savings account pursuant to Section 223 of said Internal Revenue Code, as amended from time to time, the provisions of this subsection shall apply to such plan to the maximum extent that (1) is permitted by federal law, and (2) does not disqualify such account for the deduction allowed under said Section 220 or 223, as applicable.
358 health savings account pursuant to Section 223 of said Internal Revenue Code, as amended from time to time, the provisions of this subsection shall apply to such plan to the maximum extent that (1) is permitted by federal law, and (2) does not disqualify such account for the deduction allowed under said Section 220 or 223, as applicable.
(NEW) (Effective January 1, 2023) (a) For purposes of this section:
(NEW) (Effective January 1, 2023) (a) For purposes of this Public Act No.
22-90 10 of 15 Substitute Senate Bill No.
358 section:
or (B) Positive genetic testing for the harmful variant of breast cancer gene one, breast cancer gene two or any other gene variant that LCO {\\PRDFS1\SCOUSERS\FORZANOF\WS\2022SB-0010 of 14 R02-SB.docx } Substitute Bill No.
or (B) Positive genetic testing for the harmful variant of breast cancer gene one, breast cancer gene two or any other gene variant that materially increases the insured's risk for breast cancer, ovarian cancer or any other gynecological cancers.
358 materially increases the insured's risk for breast cancer, ovarian cancer or any other gynecological cancers.
(1) Genetic testing for insureds having a family history of breast or ovarian cancer;
(1) Genetic testing for insureds having a family history of breast or Public Act No.
22-90 11 of 15 Substitute Senate Bill No.
358 ovarian cancer;
and (4) Genetic testing of the breast cancer gene one, breast cancer gene two, any other gene variant that materially increases the insured's risk for breast and ovariancancer or any other gynecological cancer to detect an increased risk for breast and ovarian cancer when recommended by a health care provider in accordance with the United States Preventive LCO {\\PRDFS1\SCOUSERS\FORZANOF\WS\2022SB-003511 of 14 R02-SB.docx } Substitute Bill No.
and (4) Genetic testing of the breast cancer gene one, breast cancer gene two, any other gene variant that materially increases the insured's risk for breast and ovariancancer or any other gynecological cancer to detect an increased risk for breast and ovarian cancer when recommended by a health care provider in accordance with the United States Preventive Services Task Force recommendations for testing.
358 Services Task Force recommendations for testing.
(c)Benefits under thissectionshallbesubject to any policy provisions that apply to other services covered by such policy, except that no such policy shall impose a coinsurance, copayment, deductible or other out- of-pocket expense for such benefits.
(c)Benefits under thissectionshallbe subject to any policy provisions that apply to other services covered by such policy, except that no such policy shall impose a coinsurance, copayment, deductible or other out- of-pocket expense for such benefits.
Sec.
Public Act No.
22-90 12 of 15 Substitute Senate Bill No.
358 Sec.
LCO {\\PRDFS1\SCOUSERS\FORZANOF\WS\2022SB-003512 of 14 R02-SB.docx } Substitute Bill No.
(2) "Surveillance tests for ovarian cancer" means annual screening using:
358 (2) "Surveillance tests for ovarian cancer" means annual screening using:
(1) Genetic testing for insureds having a family history of breast or ovarian cancer;
Public Act No.
22-90 13 of 15 Substitute Senate Bill No.
358 (1) Genetic testing for insureds having a family history of breast or ovarian cancer;
(c)Benefits under thissectionshallbesubject to any policy provisions LCO {\\PRDFS1\SCOUSERS\FORZANOF\WS\2022SB-00313 of 14 R02-SB.docx } Substitute Bill No.
(c)Benefits under thissectionshallbesubject to any policy provisions that apply to other services covered by such policy, except that no such policy shall impose a coinsurance, copayment, deductible or other out- of-pocket expense for such benefits.
358 that apply to other services covered by such policy, except that no such policy shall impose a coinsurance, copayment, deductible or other out- of-pocket expense for such benefits.
This act shall take effect as follows and shall amend the following sections:
Public Act No.
January 1, 2023 Section 1 38a-503 Sec.
22-90 14 of 15 Substitute Senate Bill No.
2 January 1, 2023 38a-530 Sec.
358 Approved May 31, 2022 Public Act No.
3 January 1, 2023 New section Sec.
22-90 15 of 15
4 January 1, 2023 New section INS Joint Favorable Subst.
APP Joint Favorable LCO {\\PRDFS1\SCOUSERS\FORZANOF\WS\2022SB-00358-14 of 14 R02-SB.docx }
⬇ Download PDF
View plain text versions (5)

How this bill changes current law

11 changes Share ↗

AI-generated reading aid from the bill's amendatory text — verify against the official bill.

The bill updates health insurance policies to ensure coverage for breast cancer screenings and related diagnostics, expanding access and detailing specific requirements for benefits.

  • Section 38a-503

    to any woman covered under the policy → for insureds

    This change clarifies the language to refer to insured individuals rather than specifically women.

  • Section 38a-503

    any woman → an insured who is

    This adjustment again specifies coverage for insured individuals, promoting inclusivity.

  • Section 38a-503

    thirty-five → Thirty-five to thirty-nine years of age, inclusive; or

    This change defines the age range for baseline mammograms more clearly.

  • Section 38a-503

    [forty] → forty years of age or older;

    This modifies the language to specify the age requirement for annual mammograms.

  • Section 38a-503

    [a woman] an insured is believed to be at increased risk for breast cancer due to: → an insured is believed to be at increased risk for breast cancer due to:

    This change ensures consistency in referring to insureds instead of gender-specific terms.

  • Section 38a-503

    [ultrasound screening] → diagnostic and screening ultrasounds

    This expands the type of ultrasound covered under the policy.

  • Section 38a-503

    [Magnetic] → Diagnostic and screening magnetic resonance imaging

    This change clarifies the type of imaging that insurance policies must cover.

  • Section 38a-503

    [a patient's] → an insured's

    This change standardizes the language to refer to individuals covered under the insurance.

  • Section 38a-530

    to any woman covered under the policy → for insureds

    Like section 38a-503, this change broadens the language to include all insured individuals.

  • Section 38a-530

    any woman → an insured who is

    This amendment again ensures inclusivity in the definition of those covered.

  • Section 38a-530

    [forty] → forty years of age or older;

    This specifies the age requirement for annual mammograms under the insurance policy.

Action History

  1. SIGNED BY GOVERNOR

  2. TRANSMITTED BY SECRETARY OF THE STATE TO GOVERNOR

  3. TRANSMITTED TO SECRETARY OF THE STATE

  4. PUBLIC ACT 22-90

  5. IN CONCURRENCE

  6. HOUSE PASSED, SEN. AMEND. SCH. A

  7. HOUSE REJECTED HOUSE AMEND. SCH. A

  8. HOUSE ADOPTED SEN. AMEND. SCH. A

  9. HOUSE CALENDAR NUMBER 493

  10. FAV. RPT., TABLED FOR HOUSE CALENDAR

  11. ON CONSENT CALENDAR

  12. SEN. PASSED, SEN. AMEND. SCH. A

  13. SEN. ADOPTED SEN. AMEND. SCH. A

  14. FAV. RPT., TAB. FOR CAL., SEN.

  15. NO NEW FILE BY COMM. ON Appropriations

  16. RPTD. OUT OF LCO

  17. FILED WITH LCO

  18. Joint Favorable

  19. REF. BY SEN. TO COMM. ON Appropriations

  20. FILE NO. 356

  21. SENATE CALENDAR NUMBER 254

  22. FAV. RPT., TAB. FOR CAL., SEN.

  23. RPTD. OUT OF LCO

  24. REFERRED TO Office of Legislative Research AND Office of Fiscal Analysis 04/05/22

  25. FILED WITH LCO

  26. Joint Favorable Substitute

  27. PUBLIC HEARING 0315

  28. REF. TO JOINT COMM. ON Insurance and Real Estate

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

62 sponsors · 0 co-sponsors · 125 not signed on

Sponsors (62)

Co-sponsors (0)

None.

Not signed on (125)

125 members have not signed on to this bill.

Show all 125 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

Who sponsors SB 358?
SB 358 is sponsored by Tom Delnicki (Republican), Susan M. Johnson (Democratic), Eleni Kavros DeGraw (Democratic), Vargas, Edwin, John-Michael Parker (Democratic), Christie M. Carpino (Republican), Michael DiGiovancarlo (Democratic), Morrin Bello, Amy, Anthony L. Nolan (Democratic), Stallworth, Charlie L., Jane M. Garibay (Democratic), Patrick S. Boyd (Democratic), Abercrombie, Catherine F., Lucy Dathan (Democratic), Cheeseman, Holly H., Kate Farrar (Democratic), John A. Kissel (Republican), Mccarthy Vahey, Cristin, Michel, David, Nicole Klarides-Ditria (Republican), Paul Cicarella (Republican), Eric C. Berthel (Republican), Ronald A. Napoli (Democratic), Frank Smith (Democratic), Gregory Haddad (Democratic), Mitch Bolinsky (Republican), Stephen R. Meskers (Democratic), Maria P. Horn (Democratic), Smith, Brian T., Devin R. Carney (Republican), Winkler, Michael A., Joan V. Hartley (Democratic), Petit, William A., Conley, Christine, Patricia A. Dillon (Democratic), Matt Blumenthal (Democratic), Tony Hwang (Republican), Heather S. Somers (Republican), Formica, Paul M., Dave W. Yaccarino (Republican), James Sanchez (Democratic), Geraldo C. Reyes (Democratic), Gucker, Kenneth M, Josh Elliott (Democratic), Carol Hall (Republican), Witkos, Kevin D., Borer, Dorinda, Saud Anwar (Democratic), Hampton, John K., Gary A. Turco (Democratic), Paris, Corey P., Ferraro, Charles J., Travis Simms (Democratic), Cook, Michelle L., Bill Buckbee (Republican), Kara Rochelle (Democratic), Young, Philip L., Kathy Kennedy (Republican), Matthew L. Lesser (Democratic), Marilyn Moore, Kevin C. Kelly, and Mccarty, K..
What is the current status of SB 358?
This bill has been enacted into law. Introduced March 07, 2022. Enacted.
Where can I track SB 358?
Track SB 358 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 358

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of SB 358

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →